A challenging time
The current situation is understandably causing many people to feel stressed and anxious. This information on the Mind website may be helpful.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
The current situation is understandably causing many people to feel stressed and anxious. This information on the Mind website may be helpful.
New European guidelines give evidence-based recommendations for the diagnosis, treatment and follow-up of people with marginal zone lymphoma.
Dwayne shares his story of mycosis fungoides, a rare type of lymphoma that develops in the skin, and how it impacted him.
NICE approves new, chemotherapy-free treatment option - lenalidomide in combination with rituximab.
There are no specific guidelines for during or after lymphoma treatment - it is recommended you follow the government guidelines.
Results of the LEGEND trial of a lenalidomide-based regimen in DLBCL have been published in the Annals of Haematology.
The European Medicines Agency has extended the licensed indications for two lymphoma treatments: rituximab and venetoclax.
The FLYER study found that four cycles of R-CHOP was no less effective than six cycles in people with stage 1 or 2 high-grade B-cell lymphoma and no risk factors.
On Time to Talk Day, our Information and Support Officers encourage anyone affected by lymphoma to contact our Helpline Services if they need someone to talk to.